For more information about REVLIMID® (lenalidomide) and the REVLIMID REMS® program, please visit www.CelgeneRiskManagement.com, or call the Celgene Customer Care Center at 1-888-423-5436. Celgene Corporation 86 Morris Ave Summit, NJ 07901 REVLIMID is only available under a restricted distribution program, REVLIMID REMS®.

“As an initial matter, Celgene disagrees with the suggestion in the Agency's question that REMS with ETASU or other distribution restrictions have prevented

REMS Companion App. Regelföljsamheten på Celgene bygger på integritet, etik, sunt beslutsfattande och uppförande som upprätthåller våra värderingar och vårt åtagande gentemot patienter. Etik och transparens Celgene säkerställer proaktivt att våra policies och metoder är ett stöd för en effektiv bolagsstyrning, transparens och ansvar. For more information about the REVLIMID REMS ® program, please visit www.CelgeneRiskManagement.com or call 1-888-423-5436. Your Celgene Patient Support ® Specialist can provide information on which pharmacy is in-network with your insurer. How can I get more information about REVLIMID ®? Your healthcare team is the best source of information. insurance, and be enrolled in a Celgene Risk Evaluation and Mitigation Strategy (REMS) program, if applicable.

For information about Celgene products and services in countries other than the U.S., please contact the local office (as listed under the Global Network). Se hela listan på revlimidhcp.com In order to prescribe POMALYST ® (pomalidomide), you must enroll in the POMALYST REMS ® program and agree to follow the requirements of the program. You can enroll by visiting CelgeneRiskManagement.com , a website that allows prescribers to handle the REMS process for all of the Celgene REMS programs. visiting www.CelgeneRiskManagement.com, accessing the Celgene REMS mobile app, or by calling the Celgene Customer Care Center for assistance at 1-888-423-5436 • Prescribers who do not have access to a computer will be provided with REVLIMID REMS® program materials.

‎Download apps by Celgene Corporation, including Celgene REMS, REMS Companion App, Cook 4 PC, and many more.

Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias.The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS). REMS - Pharmacy Network List The REMS - Pharmacy Network list includes specialty pharmacies that are contracted to fill prescriptions for restricted distribution programs for Celgene.

Submit a completed Hospital Enrollment Form. Report suspected adverse reactions to Celgene Corporation, a Bristol-Myers Squibb Company, at www.bms .com or

•After installation, do not copy Celgene REMS files or folders to new locations. Additionally, do not edit any Celgene REMS file or folder names after installation. 6. Do not manually delete the Celgene REMS programs.

För riskhanteringsaktiviteter som genomförs i USA via våra REMS-program (Risk Evaluation and Mitigation Strategy) har Celgene infört ett antal innovativa funktioner som stöd för förskrivare, apotek och patienter. Pharmacist Resources POMALYST REMS ® information for certified pharmacies. POMALYST ® (pomalidomide) is only dispensed from POMALYST REMS ® program certified pharmacies. To learn more about how to become a certified pharmacy, please contact the Celgene Customer Care Center at 1-888-423-5436. For additional information about the POMALYST REMS ® program, please contact the Celgene Customer Care Center at 1-888-423-5436 The Celgene REMS Pharmacy Portal. In addition to calling the Celgene Customer Care Center to obtain a confirmation number for a prescription, eligible pharmacies can obtain confirmation numbers using the Celgene REMS Pharmacy Portal at CelgeneREMSPharmacyPortal.com.
Hitta kunder bygg

REVLIMID ® (lenalidomide) is indicated for the treatment of patients with transfusion-dependent anemia due to low- or intermediate-1–risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. These products may not be approved and/or licensed in all countries where this website is accessible. For information about Celgene products and services in countries other than the U.S., please contact the local office (as listed under the Global Network). Se hela listan på revlimidhcp.com In order to prescribe POMALYST ® (pomalidomide), you must enroll in the POMALYST REMS ® program and agree to follow the requirements of the program. You can enroll by visiting CelgeneRiskManagement.com , a website that allows prescribers to handle the REMS process for all of the Celgene REMS programs.

Magic Tree for Breast Cancer. Celgene Corporation. Helps parents and their children (ages 5-8) talk about breast cancer. REMS Companion App. Regelföljsamheten på Celgene bygger på integritet, etik, sunt beslutsfattande och uppförande som upprätthåller våra värderingar och vårt åtagande gentemot patienter.
Amt online

It is easy to enroll in the Celgene Patient Support Program. Choose an option best for you, online, use the toll free number or email/fax. Enroll Today!

Fast Track for First Prescription®: Yes No Patient’s Celgene REMS Authorization Number PATIENT INFORMATION *First Name Middle Name *Address 1 Address 2 *City *State *Zip Code Get started in the Celgene Patient Support® program by downloading our enrollment form, in English or Spanish, and then submitting online or faxing it back. Start now! Access ABECMA REMS Training Program and Knowledge Assessment: HEALTHCARE FACILITY STAFF Access ABECMA REMS online resources: AUTHORIZED REPRESENTATIVES CONTACT. For more information about ABECMA REMS, call 1-888-423-5436.

Akademikerforbundet ssr

The REMS Companion App is a new application application that will allow patients, who reside within the United States, to conduct Risk Evaluation and

Helps parents and their children (ages 5-8) talk about breast cancer. REMS Companion App. Regelföljsamheten på Celgene bygger på integritet, etik, sunt beslutsfattande och uppförande som upprätthåller våra värderingar och vårt åtagande gentemot patienter. Etik och transparens Celgene säkerställer proaktivt att våra policies och metoder är ett stöd för en effektiv bolagsstyrning, transparens och ansvar. For more information about the REVLIMID REMS ® program, please visit www.CelgeneRiskManagement.com or call 1-888-423-5436. Your Celgene Patient Support ® Specialist can provide information on which pharmacy is in-network with your insurer.

REMS - Pharmacy Network List The REMS - Pharmacy Network list includes specialty pharmacies that are contracted to fill prescriptions for restricted distribution programs for Celgene. All pharmacies listed are certified to dispense all Celgene REMS products. Version: May 2014 – Please check

Your healthcare team is the best source of information. For additional information about the REVLIMID REMS ® program, please contact the Celgene Customer Care Center at 1-888-423-5436 6 REVLIMID REMS® patient enrollment • Obtain, review, and complete the REVLIMID® (lenalidomide) Patient-Physician Agreement Form online by visiting www.CelgeneRiskManagement.com, accessing the Celgene REMS mobile app, using the CD-ROM software, or by calling the Celgene Customer Care Center for assistance at 1-888-423-5436 • Prescribers who do not have access to a computer, or whose Learn about how Celgene, a global biopharmaceutical company, is committed to improving the lives of patients worldwide by delivering truly innovative and life-changing treatments. In order to prescribe POMALYST ® (pomalidomide), you must enroll in the POMALYST REMS ® program and agree to follow the requirements of the program. You can enroll by visiting CelgeneRiskManagement.com , a website that allows prescribers to handle the REMS process for all of the Celgene REMS programs. Download REMS Companion App App 1.0 for iPhone free online at AppPure. Get REMS Companion App for iOS latest version.

In addition to calling the Celgene Customer Care Center to obtain a confirmation number for a prescription, eligible pharmacies can obtain confirmation numbers using the Celgene REMS Pharmacy Portal at CelgeneREMSPharmacyPortal.com. Contact your Celgene Account Manager to see if your pharmacy is eligible. For more information about the THALOMID REMS ® program, please visit www.CelgeneRiskManagement.com or call 1-888-423-5436. Your Celgene Patient Support ® Specialist can provide information on which pharmacy is in-network with your insurer.